During the past decade, Fukuoka Wajiro Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fukuoka Wajiro Hospital" #1 sponsor was "Bayer" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Fukuoka Wajiro Hospital" are "Influenza" (2 trials), "Angina Pectoris" (1 trials), "Atrial Fibrillation" (1 trials), "Central Nervous System Pathology" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Fukuoka Wajiro Hospital" in a lesser frequency.

Most popular intervention types in "Fukuoka Wajiro Hospital" are "Drug" (8 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Baloxavir Marboxil" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fukuoka Wajiro Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Fukuoka Wajiro Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Fukuoka Wajiro Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fukuoka Wajiro Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".